Literature DB >> 34981333

EMT in salivary gland tumors: the expression of microRNAs miR-155 and miR-200c is associated with clinical-pathological parameters.

Leandra Ernst Kerche1, Elen Alves de Sousa1, Cristiane Helena Squarize2,3, Katia Klug Oliveira1, Fabio Albuquerque Marchi1, Bárbara Beltrame Bettim1, Luiz Paulo Kowalski4, Fernando Augusto Soares5, Silvia Vanessa Lourenço6, Cláudia Malheiros Coutinho-Camillo7.   

Abstract

BACKGROUND: Epithelial to mesenchymal transition promotes cell adhesion loss, enabling invasion and metastasis. MicroRNAs are a class of small non-codifying RNAs that regulate gene expression.
OBJECTIVES: The aim of this study was to evaluate the expression of microRNAs that could regulate the expression of EMT factors in salivary gland tumors (SGTs). METHODS AND
RESULTS: The expression of microRNAs miR-9, miR-34a, miR-101, miR-138, miR-155, and miR-200c-described in the literature to target EMT factors-was evaluated by Real-time RT-PCR (qPCR) in pleomorphic adenoma (PA), mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) samples. Bioinformatics tools were applied to identify miR targets and immunohistochemistry was used to examine the expression of the proteins E-cadherin, Twist, ZEB-1, β-Catenin, and c-Kit. Comparing miR expression among SGT types, we observed increased expression of miR-9, and miR-138 in PAs, and increased miR-155 expression in MECs. Low-grade MECs exhibited increased miR-155 expression (p = 0.032). MECs that generated lymph node metastases had increased miR-200c levels (p = 0.018). MECs tended to have decreased expression of EMT-related proteins when compared to the other SGT types (c-Kit p < 0.001, Twist p = 0.014, and ZEB p = 0.012). Notably, increased c-Kit expression was associated with the presence of perineural infiltration in ACC (p = 0.050).
CONCLUSIONS: This study provides evidence of alterations in the expression of EMT-factors regulating miRs, especially of miR-9, miR-138, miR-155, and miR-200c. No significant relationships were found between the expression of these miRs and proteins associated with EMT in SGTs.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Immunohistochemistry; Salivary gland tumors; miRNAs; qPCR

Mesh:

Substances:

Year:  2022        PMID: 34981333     DOI: 10.1007/s11033-021-07033-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Salivary Gland Tumors: Current Concepts and Controversies.

Authors:  Raja R Seethala
Journal:  Surg Pathol Clin       Date:  2017-03

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  Epithelial-mesenchymal transition in cancer development and its clinical significance.

Authors:  Masaaki Iwatsuki; Koshi Mimori; Takehiko Yokobori; Hideshi Ishi; Toru Beppu; Shoji Nakamori; Hideo Baba; Masaki Mori
Journal:  Cancer Sci       Date:  2009-10-28       Impact factor: 6.716

5.  Prognostic factors in mucoepidermoid carcinoma of the salivary glands.

Authors:  Catherine H McHugh; Dianna B Roberts; Adel K El-Naggar; Ehab Y Hanna; Adam S Garden; Merrill S Kies; Randal S Weber; Michael E Kupferman
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

Review 6.  The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2018-05-23       Impact factor: 4.304

Review 7.  Salivary gland pleomorphic adenoma.

Authors:  William M Mendenhall; Charles M Mendenhall; John W Werning; Robert S Malyapa; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2008-02       Impact factor: 2.339

8.  Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.

Authors:  Antonio Strillacci; Maria Chiara Valerii; Pasquale Sansone; Cinzia Caggiano; Annamaria Sgromo; Laura Vittori; Michelangelo Fiorentino; Gilberto Poggioli; Fernando Rizzello; Massimo Campieri; Enzo Spisni
Journal:  J Pathol       Date:  2012-11-28       Impact factor: 7.996

9.  MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.

Authors:  Xu Chen; Fan Yang; Tianze Zhang; Wei Wang; Wenjin Xi; Yufang Li; Dan Zhang; Yi Huo; Jianning Zhang; Angang Yang; Tao Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-02-22

Review 10.  Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

Authors:  Antonio Díaz-López; Gema Moreno-Bueno; Amparo Cano
Journal:  Cancer Manag Res       Date:  2014-04-25       Impact factor: 3.989

View more
  1 in total

Review 1.  The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition.

Authors:  Jing Feng; Shaofan Hu; Keli Liu; Guiyin Sun; Yiguo Zhang
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.